252 related articles for article (PubMed ID: 2519888)
1. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists.
Selak MA; Smith JB
J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888
[TBL] [Abstract][Full Text] [Related]
2. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
3. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets.
Lurie A; Dessanges JF; Delautier D; Coëffier E; Chignard M; Crémer GA; Benveniste J; Marsac J; Lockhart A
Bull Eur Physiopathol Respir; 1987; 23(4):347-51. PubMed ID: 3690021
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-activating factor (PAF) on cytosolic free calcium in human peripheral blood mononuclear leukocytes.
Ng DS; Wong K
Res Commun Chem Pathol Pharmacol; 1989 May; 64(2):351-4. PubMed ID: 2740622
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.
Nakashima S; Suganuma A; Sato M; Tohmatsu T; Nozawa Y
J Immunol; 1989 Aug; 143(4):1295-302. PubMed ID: 2545786
[TBL] [Abstract][Full Text] [Related]
6. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
8. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
9. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches.
Sánchez Crespo M; Alonso F; García Gil M; Gómez-Cambronero J; Nieto ML
Int J Tissue React; 1985; 7(5):345-9. PubMed ID: 2997066
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Wade PJ; Lunt DO; Lad N; Tuffin DP; McCullagh KG
Thromb Res; 1986 Jan; 41(2):251-62. PubMed ID: 3961730
[TBL] [Abstract][Full Text] [Related]
12. Na+/H+ exchange in PAF-stimulated platelets.
Borin ML; Pinelis VG; Azizova OA; Kudinov YV; Markov CM; Cragoe EJ; Khodorov BI
J Lipid Mediat; 1989; 1(5):257-72. PubMed ID: 2562435
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
15. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
Parnham MJ; Bittner C; Lambrecht G
Br J Pharmacol; 1989 Oct; 98(2):574-80. PubMed ID: 2819335
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
18. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
19. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
Yi FX; Guo ZG
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
Cox CP; Wood KL
Thromb Res; 1987 Aug; 47(3):249-57. PubMed ID: 3629553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
